Annual report pursuant to Section 13 and 15(d)

SHARE-BASED COMPENSATION - Schedule of Stock Option Activity (Details)

v3.22.0.1
SHARE-BASED COMPENSATION - Schedule of Stock Option Activity (Details)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Options (in shares):  
Outstanding at beginning of period (in shares) 14,152
Granted (in shares) 1,883
Assumed (in shares) 844
Exercised (in shares) (1,850)
Forfeited/expired (in shares) (563)
Outstanding at end of period (in shares) 14,466
Expected to vest at end of period (in shares) 6,795
Exercisable at end of period (in shares) 7,531
Weighted- Average Exercise Price (USD per share):  
Outstanding at beginning of period (USD per share) | $ / shares $ 11.55
Granted (USD per share) | $ / shares 16.04
Assumptions (USD per share) | $ / shares 12.02
Exercised (USD per share) | $ / shares 10.36
Forfeited/expired (USD per share) | $ / shares 11.01
Outstanding at end of period (USD per share) | $ / shares 12.34
Vested and expected to vest (USD per share) | $ / shares 12.23
Exercisable (USD per share) | $ / shares $ 12.43
Weighted-Average Remaining Contractual Life (Years)/Aggregate Intrinsic Value  
Outstanding, weighted-average remaining contractual life (years) 6 years 10 months 24 days
Expected to vest, weighted-average remaining contractual period (years) 5 years 8 months 12 days
Exercisable, weighted-average remaining contractual term (years) 8 years 2 months 12 days
Outstanding aggregate intrinsic value | $ $ 46
Expected to vest, aggregate intrinsic value | $ 23
Exercisable, aggregate intrinsic value | $ $ 23
Expected to be forfeited (in shares) 140